539680 — GANGA PHARMACEUTICALS Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹73.89m
- IN₹84.21m
- IN₹28.28m
Annual cashflow statement for GANGA PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 0.531 | 0.633 | 0.947 | 1.29 |
| Depreciation | ||||
| Non-Cash Items | -1.11 | -0.585 | -2.67 | -1.56 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.378 | -13.2 | -4.51 | -13.4 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.399 | -12.6 | -5.77 | -13.1 |
| Capital Expenditures | -0.148 | -0.224 | -0.987 | -0.369 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 5.07 | 1.52 | 12.8 | 2.81 |
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 4.92 | 1.3 | 11.8 | 2.44 |
| Financing Cash Flow Items | -1.87 | -1.81 | -1.69 | -1.23 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -4.44 | 11.4 | -3.32 | 8.23 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.086 | 0.008 | 2.73 | -2.44 |